Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies have?
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies has 496 citations in the OpenAlex counts ScholarIQ stores.
When was Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies published?
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies has 2012 year in the ScholarIQ index.
What is the open-access status of Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies?
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies has closed oa status in the ScholarIQ index.
What is the DOI of Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies?
The DOI for Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies is on the source record.
What is the PMID of Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies?
The PMID for Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies is on the source record.
What is the OpenAlex record for Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies?
The OpenAlex for Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies is on the source record.